Product Name:

NebuPeptide™ Voclosporin (Peptide Reference)

Catalog Number:

NBS-233787

Description:

NebuPeptide™ Voclosporin (Peptide Reference)(CAT#NBS-233787) is synthesized in accordance with the Voclosporin sequence and can be utilized for a variety of in vivo and in vitro studies, including quality control, bioactivity verification, immunization, drug development, structural analysis, etc. Nebula Biotechnology Co., Ltd. is capable of providing Lixisenatide reference peptide ranging from milligrams to kilograms.

Peptide Name:

Voclosporin (伏环孢素)

Background:

Voclosporin (ISATX247; LX211; LX 214; Luveniq; Lupkynis) is a novel and potent calcineurin inhibitor approved in January 2021 by the US FDA for use as an immunosuppressant medication to treat lupus nephritis. Voclosporin is an immunosuppressant that binds and inhibits calcineurin, a type of protein found in the body. It can reduce the activation of T cells and stabilizes podocytes, thereby reducing proteinuria.

Alias:

ISATX247; LX211; LX 214; ISATX-247; LX-211; LX-214; Luveniq; Lupkynis; Voclosporin; ISA247; ISAtx-247; ISAtx247; ISAtx 247

CAS Number:

515814-01-4

Formula:

C63H111N11O12

Molecular Weight:

1214.62

Purity:

see COA

Solubility:

see COA

Storage & Shipment:

Store at -20℃; ship with blue ice.

For R&D use only!

To get more information, please contact us freely.